{"pageContent": "Background: Prostate cancer is a frequently diagnosed cancer and made up 6% of male cancer deaths globally in 2008. Its incidence varies more than 25-fold worldwide, which is primarily attributed to the implementation of the prostate-specific antigen (PSA) test in developed countries. To reduce harm of overdiagnosis, most international guidelines recommend surveillance programmes. However, this approach can entail negative psychosocial consequences from being under surveillance for an (over)diagnosed prostate cancer.", "metaData": {"source": "Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey\nhttps://pubmed.ncbi.nlm.nih.gov/21507471/"}}